(Q34382536)

1 August 2017

1 reference

title

Primary sclerosing cholangitis: updates in diagnosis and therapy (English)

1 reference

1 August 2017

main subject

ascending cholangitis

0 references

sclerosing cholangitis

1 reference

primary sclerosing cholangitis

inferred from title

1 reference

6

Karel J van Erpecum

1 reference

1 August 2017

Piero Portincasa

1

1 reference

1 August 2017

Michele Vacca

2

1 reference

1 August 2017

Antonio Moschetta

3

1 reference

1 August 2017

Michele Petruzzelli

4

1 reference

1 August 2017

Giuseppe Palasciano

5

1 reference

1 August 2017

Gerard P van Berge-Henegouwen

7

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

World Journal of Gastroenterology

1 August 2017

published in

1 reference

1 August 2017

volume

11

1 reference

1 August 2017

issue

1

1 reference

1 August 2017

page(s)

7-16

1 reference

Treatment Options for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Management of primary sclerosing cholangitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Natural bile acids and synthetic analogues modulate large conductance Ca2+-activated K+ (BKCa) channel activity in smooth muscle cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Hepatic transport of bile salts

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Surgical treatment for primary sclerosing cholangitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Prevention and treatment of osteoporosis in primary biliary cirrhosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Primary sclerosing cholangitis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Mechanism of hepatoprotective action of bile salts in liver disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Primary sclerosing cholangitis: a clinical review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Ludwig Symposium on biliary disorders--part II. Pathologic features and evolution of primary biliary cirrhosis and primary sclerosing cholangitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Ursodeoxycholic acid in the treatment of liver diseases

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Increased gall bladder volume in primary sclerosing cholangitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Effects of tauroursodeoxycholic acid on cytosolic Ca2+ signals in isolated rat hepatocytes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Ursodiol for hepatobiliary disorders

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Pharmacology of ursodeoxycholic acid, an enterohepatic drug.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Prognostic value of cholangiography in primary sclerosing cholangitis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Ursodeoxycholate increases cytosolic calcium concentration and activates CI− currents in a biliary cell line

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Part II.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Elevated circulating immune complexes in primary sclerosing cholangitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Association of primary sclerosing cholangitis with HLA-B8.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Human Liver Transplantation: Analysis of Data on 540 Patients from Four Centers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Primary sclerosing cholangitis. A study of forty-two cases

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Transection of the oesophagus for bleeding oesophageal varices

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Portal bacteraemia in cases of ulcerative colitis submitted to colectomy.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Effect of side-chain shortening on the physiologic properties of bile acids: hepatic transport and effect on biliary secretion of 23-nor-ursodeoxycholate in rodents.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Diagnosis and treatment of primary sclerosing cholangitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

An autoantibody profile in primary sclerosing cholangitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Prospective trial of penicillamine in primary sclerosing cholangitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Lymphocyte subsets in primary sclerosing cholangitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Floxuridine-induced sclerosing cholangitis: an ischemic cholangiopathy?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

The syndrome of primary sclerosing cholangitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Endoscopic and radiologic approaches to therapy in primary sclerosing cholangitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Histological and immunohistochemical study of the gall bladder lesion in primary sclerosing cholangitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Ulcerative colitis disease activity as subjectively assessed by patient-completed questionnaires following orthotopic liver transplantation for sclerosing cholangitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

The combination of prednisone and colchicine in patients with primary sclerosing cholangitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Hepatocellular and biliary expression of HLA antigens in primary biliary cirrhosis before and after ursodeoxycholic acid therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Fasting gallbladder volume, postprandial emptying and cholecystokinin release in gallstone patients and normal subjects

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

A new look at the arterial supply of the bile duct in man and its surgical implications

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Ursodeoxycholic acid versus chenodeoxycholic acid. Comparison of their effects on bile acid and bile lipid composition in patients with cholesterol gallstones

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Transdermal nicotine for active ulcerative colitis

6 July 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I1.7

No beneficial effects of transdermal nicotine in patients with primary sclerosing cholangitis: results of a randomized double-blind placebo-controlled cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I1.7

Primary sclerosing cholangitis in children: a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I1.7

Three-dimensional magnetic resonance cholangiopancreatography with respiratory triggering in the diagnosis of primary sclerosing cholangitis: comparison with endoscopic retrograde cholangiography

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I1.7

The extrahepatic bile duct lesions in end-stage primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I1.7

Hydrophilic bile salts enhance differential distribution of sphingomyelin and phosphatidylcholine between micellar and vesicular phases: potential implications for their effects in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I1.7

Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I1.7

Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I1.7

A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I1.7

High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I1.7

Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I1.7

Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I1.7

Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I1.7

Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I1.7

Tauroursodeoxycholic acid, ursodeoxycholic acid and gallbladder motility in gallstone patients and healthy subjects.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205387

Combined Therapy with Azathioprine, Prednisolone, and Ursodiol in Patients with Primary Sclerosing Cholangitis: A Case Series

27 October 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I1.7

Behavior of various cholesterol crystals in bile from patients with gallstones

21 January 2018

1 reference

12 December 2020

Hypercholeresis induced by ursodeoxycholic acid and 7-ketolithocholic acid in the rat: possible role of bicarbonate transport

1 reference

12 December 2020

[Primary sclerosing cholangitis]

1 reference

12 December 2020

Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis

1 reference

12 December 2020

[MRCP in primary sclerosing cholangitis]

1 reference

12 December 2020

Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid

1 reference

12 December 2020

Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis

1 reference

12 December 2020

Primary sclerosing cholangitis: findings on cholangiography and pancreatography

1 reference

12 December 2020

Association of primary sclerosing cholangitis with HLA-DRw52a

1 reference

12 December 2020

Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids

1 reference

12 December 2020

Primary sclerosing cholangitis

1 reference

12 December 2020

Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis

1 reference

12 December 2020

Primary sclerosing cholangitis: a long-term follow-up study

1 reference

12 December 2020

Primary sclerosing cholangitis: liver transplantation or biliary surgery

1 reference

12 December 2020

Surgical aspects of sclerosing cholangitis. Results in 178 patients

1 reference

12 December 2020

Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system

1 reference

12 December 2020

Increased serum deoxycholic acid levels in men with colorectal adenomas

1 reference

12 December 2020

Therapeutic biliary endoscopy

1 reference

12 December 2020

Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. part I

1 reference

12 December 2020

The in vivo metabolism of C3 in hepatobiliary disease associated with ulcerative colitis

1 reference

12 December 2020

Liver transplantation for primary sclerosing cholangitis

1 reference

12 December 2020

Sclerosing cholangitis: broad spectrum of radiographic features

1 reference

12 December 2020

Intrahepatic cholangiectases and large-duct obliteration in primary sclerosing cholangitis

1 reference

12 December 2020

Endoscopic treatment of biliary tract strictures in sclerosing cholangitis: a larger series and recommendations for treatment

1 reference

12 December 2020

Effect of ursodeoxycholic acid on the kinetics of cholic acid and chenodeoxycholic acid in patients with primary sclerosing cholangitis

1 reference

12 December 2020

Gallbladder disease in patients with primary sclerosing cholangitis

1 reference

12 December 2020

HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease

1 reference

12 December 2020

Primary sclerosing cholangitis: the emerging role for liver transplantation

1 reference

12 December 2020

Is primary sclerosing cholangitis a progressive disease or not?

1 reference

12 December 2020

Management of osteoporosis in primary biliary cirrhosis

1 reference

12 December 2020

Ursodeoxycholic acid reduces protein levels and nucleation-promoting activity in human gallbladder bile

1 reference

12 December 2020

Cystic dilatation as a radiographic sign of cholangiocarcinoma complicating sclerosing cholangitis

1 reference

12 December 2020

Percutaneous dilatation in primary sclerosing cholangitis: two experiences

1 reference

12 December 2020

Ulcerative colitis and persistent liver dysfunction

1 reference

12 December 2020

Endoscopic treatment of biliary duct strictures in sclerosing cholangitis: follow-up assessment of a new therapeutic approach

1 reference

12 December 2020

Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis

1 reference

12 December 2020

A comparative study of patients undergoing liver transplantation for primary sclerosing cholangitis and primary biliary cirrhosis

1 reference

12 December 2020

Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period

1 reference

12 December 2020

Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses

1 reference

12 December 2020

Nonoperative dilatation of dominant strictures in primary sclerosing cholangitis

1 reference

12 December 2020

Faecal bile acids, dysplasia, and carcinoma in ulcerative colitis

1 reference

12 December 2020

Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial

1 reference

12 December 2020

Risk of primary sclerosing cholangitis is associated with nonsmoking behavior

1 reference

12 December 2020

Hepatobiliary disease that precedes ulcerative colitis

1 reference

12 December 2020

MR imaging features of primary sclerosing cholangitis: patterns of cirrhosis in relationship to clinical severity of disease

1 reference

12 December 2020

Primary sclerosing cholangitis with normal serum alkaline phosphatase activity

1 reference

12 December 2020

Influence of cholestasis on absorption of ursodeoxycholic acid

1 reference

12 December 2020

Clinicopathologic features of the syndrome of primary sclerosing cholangitis

1 reference

12 December 2020

High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis

1 reference

12 December 2020

Hepatobiliary complications of inflammatory bowel disease

1 reference

12 December 2020

Cholangiocarcinoma complicating primary sclerosing cholangitis: cholangiographic appearances

1 reference

12 December 2020

Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V11.I1.7

1 reference

1 August 2017

1 reference

1 August 2017

1 reference